The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

3 Jan 2020 11:20

RNS Number : 7119Y
Pathfinder Minerals Plc
03 January 2020
 

3 January 2020

 

Pathfinder Minerals Plc

 

("Pathfinder" or the "Company")

 

Corporate Update

 

Pathfinder (AIM: PFP) is pleased to provide an update on its progress towards restoring an interest in Mining Concession 4623C in Mozambique (the "Licence") and on other (unconnected) commercial opportunities that have been presented to the Board of Directors of Pathfinder (the "Board") to assess.

 

As announced on 24 October 2019, a period of meetings took place in both South Africa and Mozambique in that month between members of the Board, its representatives and various key stakeholders involved in the process of working to secure a resolution of the issues surrounding the Company's previous interest in the Licence. Since then, two further rounds of meetings have been undertaken by Board representatives in Mozambique and South Africa to intensify the progress and further meetings are planned for this month.

 

A number of additional meetings have been conducted with the preferred funding partner which, as announced on 24 October 2019, is both technically competent and has the means to fund both a settlement itself and future development costs associated with the Licence. The party is continuing with its due diligence process. In addition, further dialogue has been conducted with the shareholders of Pathfinder Moçambique S.A. (the current Licence holder) with a view to concluding a mutually acceptable settlement in respect of the Licence. These discussions continue in good faith and have been facilitated by Africa Focus Group ("AFG") at every stage.

 

The Company announced on 24 October 2019 that the agreement with AFG was extended until 31 December 2019 and, given the ongoing progress that continues to be made with all parties, the Board has determined it in the interests of the Company to extend this agreement for a further three months on a non-exclusive basis. This allows the Board to explore other funding avenues unilaterally and to pursue other commercial opportunities where there is a clear synergy with the Board's expertise and the Company's natural resource focus. All other terms of the agreement with AFG remain the same.

 

As previously stated, while the Board remains confident of a successful resolution of the dispute surrounding the Licence, there is no certainty that this can be achieved to the satisfaction of all stakeholders within a timely manner. As such, the Board believes that it is in the interests of the Company also to assess other appropriate commercial opportunities. Accordingly, the Board is actively assessing two independent opportunities, with due diligence on their suitability for Pathfinder now at an advanced stage. The key consideration in any decision-making is whether a broadening of interests beyond the Licence will assist the Board in recovering shareholder value and generating future additional value through cash generation that would alleviate the pressure for future, potentially dilutive, funding requirements associated with Pathfinder's prospective interest in the Licence. It is highly likely that any decision to be taken by the Board in respect of restoring an interest in the Licence and/or pursuing other such opportunities would require the approval of shareholders by way of a General Meeting.

 

John Taylor, Chief Executive Officer of Pathfinder, commented:

 

"I continue to be encouraged by the progress made since our last update which reflects the considerable efforts of my fellow directors in relentlessly pursuing a successful outcome to the recovery of an interest in the Licence. In addition, I believe the strategic decision to also explore wider commercial interests is the correct course of action to take. The Board's focus remains firmly on a successful resolution of the long-running dispute over the Licence and consideration of wider opportunities will not detract from that priority. I look forward to updating shareholders on further progress across a number of fronts."

 

Enquiries:

Pathfinder Minerals Plc

John Taylor, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFXLFBBFLFBBD
Date   Source Headline
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants
6th May 20223:10 pmRNSIssue of Equity and TVR
12th Apr 20227:00 amRNSCompany Strategy Update
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
4th Oct 20214:30 pmRNSGrant of Share Options
14th Sep 20217:00 amRNSHalf-year Results
19th Jul 20213:13 pmRNSChange of Registered Office
30th Jun 202111:47 amRNSResult of Annual General Meeting
29th Jun 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
24th Jun 202111:00 amRNSGrant of Share Options
9th Jun 202110:38 amRNSGrant of Share Options
7th Jun 20217:02 amRNSChange of Adviser
7th Jun 20217:01 amRNSNotice of AGM
7th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSDirector Appointment
21st May 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
12th May 20215:40 pmRNSHolding(s) in Company
12th May 202112:33 pmRNSHolding(s) in Company
4th May 20213:40 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
1st Apr 20215:58 pmRNSGrant of Share Options
1st Apr 20215:57 pmRNSHolding(s) in Company
29th Mar 20212:07 pmRNSResult of General Meeting - Replacement
29th Mar 202112:29 pmRNSResult of General Meeting
17th Mar 20217:00 amRNSDirectorate Change
10th Mar 20217:00 amRNSNotice of General Meeting
1st Mar 202110:59 amRNSChange of Auditor
19th Feb 20213:34 pmRNSStrategy Update, Placing, CLN Amendment & TVR
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
20th Jan 202112:22 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
6th Jan 20212:01 pmRNSPrice Monitoring Extension
29th Dec 20204:32 pmRNSDirector/PDMR Shareholding
16th Dec 20203:32 pmRNSBilateral Investment Treaty Claim – Legal Opinion
11th Dec 20207:00 amRNSUpdate Re Mining Licence
30th Nov 20207:00 amRNSRecovery of Costs Awards
18th Nov 20205:15 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSCLN Conversion and Final Settlement
5th Nov 202011:32 amRNSCLN Maturity Date
4th Nov 20207:00 amRNSIssue of Warrants
2nd Nov 20207:00 amRNSCompany Strategy Update
30th Oct 20207:00 amRNSHalf-year Report
29th Oct 20207:00 amRNSChange of Admission Date
22nd Oct 20207:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.